Search Results

QuPID® Plus E.R. pregnancy device is intended for qualitative determination of human chorionic gonadotropin (hCG) in serum or urine to aid in the early detection of pregnancy.

Device Description

The test is comprised of colored dye coated with polyclonal antibodies specific for hCG, immobilized antibodies against hCG and monoclonal anti-mouse lgG antibodies. The assay is conducted by adding specimen, urine or serum, to the test device and observing for the formation of colored lines. The specimen migrates via capillary action along the membrane to react with the colored conjugate. Positive specimens react with the specific antibody hCG colored conjugate and form a colored line in the Specimen Area of the membrane. Absence of this colored line suggests a negative result. To serve as a procedural control, a colored line in the Control Area will always appear regardless of the presence or absence of hCG.

AI/ML Overview

The QuPID® Plus E.R. pregnancy device is intended for the qualitative determination of human chorionic gonadotropin (hCG) in serum or urine to aid in the early detection of pregnancy.

Here's an analysis of the acceptance criteria and the study that proves the device meets them:

1. Table of Acceptance Criteria and Reported Device Performance

Acceptance Criteria Category	Specific Acceptance Criteria (Implied)	Reported Device Performance
Accuracy	High concordance with a commercially available (predicate) test.	100% concordance with a commercially available test for both urine (n=300) and serum (n=72) specimens.
Specificity	No cross-reactivity with hLH, hFSH, and hTSH at specified concentrations.	No cross-reactivity observed with hLH (500 mIU/ml), hFSH (1000 mIU/ml), and hTSH (1000 µIU/mL).
Sensitivity	Detect hCG at a clinically relevant threshold.	Detects hCG concentration of 10 mIU/mL or greater in serum and 20 mIU/mL in urine.
Standardization	Standardized to an international reference.	Standardized to the World Health Organization (WHO) Third International Standard.
Clinical Performance	High concordance with other commercially available tests in diverse settings.	100% concordance with other commercially available tests observed in clinical studies at three locations with diverse personnel.

2. Sample Sizes Used for the Test Set and Data Provenance

Test Set Sample Size:
- Accuracy Study: 300 urine specimens and 72 serum specimens.
- Specificity Study: Not explicitly stated, but implies positive and negative urine/serum specimens were used after addition of interfering substances.
- Sensitivity Study: Not explicitly stated, but implied by the detection thresholds (10 mIU/mL in serum, 20 mIU/mL in urine).
- Clinical Studies: Not explicitly stated, but the results showed 100% concordance with other tests. Given the statement of 100% concordance, this would imply a sufficient sample size to establish this, though the exact number is missing for the overall clinical studies.
Data Provenance: The document does not specify the country of origin of the data. It appears to be a retrospective comparison study against a predicate device.

3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications of Those Experts

The document does not explicitly state the number of experts or their qualifications used to establish the "ground truth" for the test set. Instead, the "ground truth" for comparative effectiveness was established by the results from a "commercially available urine/serum membrane test" (predicate device) and "other commercially available tests" for the clinical studies. The performance of these predicate devices is assumed to be the reference standard.

4. Adjudication Method for the Test Set

No explicit adjudication method (e.g., 2+1, 3+1) is mentioned. The study design primarily involved comparing the QuPID® Plus E.R. results directly with the results of the predicate devices. The "ground truth" was established by the predicate device's output.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

No, an MRMC comparative effectiveness study was not done. The study focused on the performance of the device itself compared to predicate devices, not on the improvement of human readers with or without AI assistance. This device is a rapid diagnostic test (RDT), not an AI-assisted diagnostic tool for interpretation by human readers.

6. Standalone Performance

Yes, a standalone performance assessment was done. The accuracy, specificity, and sensitivity studies directly evaluated the QuPID® Plus E.R. device's performance characteristics independently, using predicate devices as internal controls or reference standards. The "100% concordance" specifically speaks to its standalone ability to yield results consistent with established methods.

7. Type of Ground Truth Used

The primary type of "ground truth" used was comparison to a predicate device / commercially available test. For the accuracy and clinical studies, the results from established, legally marketed pregnancy tests served as the reference. For specificity, spiked samples with known interfering substances were used. For sensitivity, likely samples with known hCG concentrations were used (though not explicitly detailed how these were prepared/validated).

8. Sample Size for the Training Set

The document does not mention separate "training sets" or "test sets" in the context of machine learning. This is a traditional in-vitro diagnostic device, not an AI/ML-based device. Therefore, the concept of a training set as understood in AI development is not applicable here. The "training" of the device is inherent in its manufacturing and quality control processes to ensure it meets performance specifications.

9. How the Ground Truth for the Training Set Was Established

As explained above, there is no "training set" in the AI/ML sense for this device. The ground truth for establishing the device's operational parameters (e.g., antibody concentrations, conjugate characteristics) would have been based on established biochemical principles, antigen-antibody interactions, and calibration against international standards like the WHO Third International Standard for hCG.

Ask a Question

Ask a specific question about this device

Page 1 of 1